Results 281 to 290 of about 10,512,166 (412)
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
Colorectal Cancer: Pathogenesis and Targeted Therapy. [PDF]
Li J, Pan J, Wang L, Ji G, Dang Y.
europepmc +1 more source
Harnessing lentiviral vectors for in vivo gene therapy of liver metastases
Giovanna Giacca+2 more
doaj +1 more source
Current and future antifungal therapy: new targets for antifungal therapy
Vincent T. Andriole
openalex +1 more source
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho+11 more
wiley +1 more source
Targeted therapy: What are the targets?
openaire +3 more sources
A transgenic mouse line that develops early‐onset invasive gastric carcinoma provides a model for carcinoembryonic antigen‐targeted tumor therapy [PDF]
John A. Thompson+6 more
openalex +1 more source
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski+19 more
wiley +1 more source
Targeted therapy for idiopathic pulmonary fibrosis: a bibliometric analysis of 2004-2024. [PDF]
Zhang X, Yuan Z, Shi X, Yang J.
europepmc +1 more source